SLC38A6 expression in macrophages exacerbates pulmonary inflammation

Area of Science:

• Immunology
• Metabolic pathways
• Cellular biology

Background:

• Pulmonary inflammation involves complex immune cell dynamics, with macrophages playing a critical role.
• Macrophage function is potentially modulated by metabolic processes.
• The amino acid transporter Slc38a6 facilitates nutrient uptake in macrophages (Mφ).

Purpose of the Study:

• To investigate the role of Slc38a6 in pulmonary inflammation.
• To explore the relationship between SLC38A6 expression and inflammatory markers.
• To identify potential therapeutic targets for pulmonary inflammation.

Main Methods:

• Analysis of SLC38A6 expression in pneumonia patient blood and LPS-induced sepsis mice.
• Utilizing systemic and conditional Slc38a6 knockout mice (including LyzCRE-specific).
• Employing flow cytometry to quantify immune cells.
• Investigating the TLR4 signaling pathway using TAK242 inhibitor and TLR4 knockout models.

Main Results:

• SLC38A6 expression was upregulated in pneumonia patients and sepsis mice, correlating with monocyte and white blood cell counts.
• Slc38a6 knockout, either systemically or in macrophages, reduced sepsis severity, pro-inflammatory cytokine (TNF-α, IL-1β) levels, and monocyte infiltration.
• TLR4 signaling inhibition or knockout downregulated SLC38A6 expression in macrophages.
• Overexpression of SLC38A6 in macrophages contributed to IL-1β expression, even when TLR4 was inhibited.

Conclusions:

• SLC38A6, an amino acid transporter, is upregulated in monocytes/macrophages during pulmonary inflammation.
• Upregulated SLC38A6 promotes immune cell activation and contributes to inflammatory processes.
• SLC38A6 represents a potential therapeutic target for pulmonary inflammation.